Case Study: Reflections on Evidence-Based Practice, Clinical Practice Guidelines, and Standards of Care

Case Study: Reflections on Evidence-Based Practice, Clinical Practice Guidelines, and Standards of Care

Patient Case Summary

S.T., a 27-year-old African American female, was diagnosed with bipolar disorder with mixed features and psychotic symptoms and generalized anxiety disorder (GAD). Her sister brought her in for a follow-up appointment. The patient had been off medication for one year and was seen with delusional ideation, emotional distress, paranoia, and distrustfulness. She was unemployed, withdrawn, and initially treatment-resistant, though she later consented to resume medication. The first injection of Invega Sustenna 156 mg IM was given to her. She complained of confusion and forgetfulness in her second visit, which was suspected to be side effects of her medication. Her hallucinations had diminished, and she was interested in going back to work. She was started on a reduced dose of Invega Sustenna 117 mg IM, and benztropine and lorazepam were continued. The treatment plan had an emphasis on medication taking and monitoring cognitive symptoms.

Comparison of Treatment Plans

In the treatment plan proposed by my preceptor, pharmacologic management had top priority, with the emphasis on psychotropic administration, regularity of follow-ups, and prescription refills. It did not involve much therapeutic discourse beyond simple education about medication. Conversely, my treatment plan included clinical recommendations regarding a holistic model of care. I ensured proper patient education, discussed the possibility of any side effects of medication, and solved the psychosocial issues affecting the patient. Besides maintaining her medications, I proposed cognitive observation, supported psychosocial rehabilitation, and suggested that she wait to resume work until mental clarity was restored. Although we were in agreement on the diagnosis and drug treatment strategies, the way in which we were to provide care differed considerably.

Evidence-Based Justification of My Approach

The strategies that I employed were clearly based on established clinical guidelines like the American Psychiatric Association (APA), which advises the use of a combination of psychotherapy and pharmacotherapy in the treatment of mental illnesses. Sarkhel et al. (2020) support the rationale that structured psychoeducation and shared decision-making should be combined in the treatment of psychiatric disorders to achieve the most effective treatment and long-term results. Besides, best practice for antipsychotic use is careful monitoring for extrapyramidal and cognitive side effects. Treatment for S.T.’s forgetfulness and confusion is necessary, given her previous nonadherence. Promoting reintegration into social life and delaying back-to-work is essential because it ensures cognitive stabilization prior to occupational reentry.

Effectiveness of My Approach

I believe my patient-centered approach would be effective because it emphasizes therapeutic alliance, informed decision making, and psychosocial rehabilitation. S.T.’s willingness to engage in therapy and desire to return to work indicated motivation to improve, but her cognitive complaints necessitated cautious progression. A supportive but structured environment, with clear education and close monitoring, would help her be compliant with her treatment and gain confidence (Wu et al., 2022). By addressing her concerns, I aimed to prevent relapse, enhance adherence, and empower the patient in her recovery. Since she had a history of nonadherence, the extra time spent establishing rapport with her was an investment toward long-term results.

Differences in Clinical Approach

The significant differences between my plan and my preceptor’s were the level of engagement and use of communication approaches. My preceptor, although skilled and competent, focused more on medication adherence and prescription management. I took a more comprehensive approach by exploring the patient’s subjective complaints, emotional state, and functional goals. While the pharmacological plan was brought up, my plan incorporated psychosocial components and plans for the patient’s future functioning. I also prioritized the management of side effects, therapy referral, and preparedness to work, issues that were not addressed by my preceptor’s interaction with the patient.

Influences on Treatment Decisions

Several factors influenced the difference in our approaches. My preceptor’s decisions reflected efficiency and clinical experience, relying on medication as the central intervention. I, however, integrated patient-centered care and evidence-based practices, emphasizing empathy and collaboration. My academic foundation and recent training in shared decision-making influenced my drive to foster rapport and patient participation. While clinical experience resulted in the majority of seasoned practitioners prioritizing stabilization, I valued building therapeutic trust as it is key to sustaining long-term engagement and safety for patients with a history of nonadherence and psychosis.

Lessons Learned from the Experience

This experience reinforced the importance of achieving balance between pharmacologic treatment and therapeutic rapport. I discovered that quality psychiatric care depends not only on diagnosis and prescription but also on the patient being aware, complying, and trusting in the process. It supported the idea that although effectiveness is crucial, depth of dialogue can uncover critical aspects that influence clinical outcomes. This case reconfirmed the need for listening, educating, and empowering patients regarding their fears and uncertainties, especially when working with conditions like psychosis and bipolar disorder.

Application to Future Practice

In future practice, I will utilize therapeutic communication along with evidence-based pharmacologic therapies. Moreover, I will use motivational interviewing techniques and psychoeducation resources to overcome reluctant patients and improve compliance. Side effects tracking of medications, especially cognitive ones, is a critical component in practice and will apply this in future practice (Do & Schnittker, 2020). I also intend to encourage recovery-oriented outcomes and psychosocial support services in collaboration with patients. Building trust and patient-tailored treatment aligned with patient goals will guide my practice as I interact with diverse psychiatric populations.

Collaborative Professional Dialogue

When treatment plans contradict those of a colleague or preceptor, I will approach the situation with respect and professionalism. I will first attempt to understand their approach, and then share alternative perspectives based on supporting evidence. Open constructive dialogue, guided by clinical guidelines and patient-centered outcomes, fosters mutual learning and improved care. I will focus on shared interests, including safety and compliance, and provide my proposals humbly and in a team-oriented manner. This strategy enhances respect across interdisciplinary boundaries while ensuring that patients get the most thorough and considerate care.

References

Do, D., & Schnittker, J. (2020). Utilization of medications with cognitive impairment side effects and the implications for older adults’ cognitive function. Journal of Aging and Health, 32(9), 089826431989584. https://doi.org/10.1177/0898264319895842

Sarkhel, S., Singh, O., & Arora, M. (2020). Clinical practice guidelines for psychoeducation in psychiatric disorders general principles of psychoeducation. Indian Journal of Psychiatry, 62(8). https://doi.org/10.4103/psychiatry.indianjpsychiatry_780_19

Wu, D., Lowry, P. B., Zhang, D., & Tao, Y. (2022). Patient trust in physicians matters—Understanding the role of a mobile patient education system and patient-physician communication in improving patient adherence behavior: Field study. Journal of Medical Internet Research, 24(12). https://doi.org/10.2196/42941

ORDER A PLAGIARISM-FREE PAPER HERE

We’ll write everything from scratch

Case Study: Reflections on Evidence-Based Practice, Clinical Practice Guidelines, and Standards of Care

Identify a Case:
Choose a patient case from your clinical experience where you and your preceptor approached the treatment plan differently.
Research evidence-based information pertinent to your chosen patient for treatment Clinical Practice Guidelines and Standards of Care.
Submission Requirements:

Reflections on Evidence-Based Practice, Clinical Practice Guidelines, and Standards of Care

Length: 3-4 pages, double-spaced, APA format.
Cite at least 3 peer-reviewed sources to support your analysis.
Evaluation Criteria:

Clarity and completeness of the case summary.
Depth of analysis and comparison between treatment plans.
Use of evidence-based rationale for your alternative plan.
Reflection on learning and future application.
Proper use of APA formatting and references.

The case study patient: the 1st assessment with and the 2nd assessment:
S.T., a 27-year-old female diagnosed with bipolar disorder with mixed features and psychotic symptoms, as well as GAD, presented for a follow-up appointment accompanied by her sister. The patient was well-groomed and seasonally dressed. She appeared emotionally distressed, withdrawn, tearful, and exhibited a flight of ideas. Her sister assisted with communication and reported recent episodes of delusional thoughts and hallucinations, including a false belief about a sexual assault and ongoing paranoia. The patient expressed distrust of others, including family, and stated she has been off medication for the past year. She is currently unemployed and socially withdrawn due to fear of others. While initially resistant to restarting medication, the patient agreed after encouragement from her sister. She expressed interest in engaging in therapy.
Intervention:
• Administered Invega Sustenna 156 mg IM in the right deltoid, well tolerated
• Educated patient and sister on importance of medication adherence and therapy
• Scheduled follow-up in one week for second (234 mg) loading dose

2nd assessment
S.T.,a 27-year-old African American female with bipolar disorder and GAD, presents with her sister for psychotropic medication review. She reports recent hospitalization but feels improved. She expresses concerns about confusion and forgetfulness, which she attributes to her medications. Denies hallucinations, appetite or sleep changes, and reports continued social isolation. She expressed interest in returning to work but was advised to postpone it until her cognitive symptoms improve. She received education on potential medication side effects and the significance of adherence, a message that both the patient and her sister verbally understood. Invega Sustenna 117 mg was administered intramuscularly to the left deltoid without any issues. Refill will be sent to the pharmacy. Follow-up scheduled in 4 weeks.
Current Medications:
• Benztropine Mesylate 1 mg tablet, orally, once daily
• Invega Sustenna 234 mg/1.5 mL injection, intramuscularly, monthly (last administered: 117 mg IM today)
• Lorazepam 0.5 mg tablet, orally, nightly
Plan of Care:
• Continue the current medication regimen without changes.
• Monitor cognitive symptoms (confusion, forgetfulness); reassess at next visit.
• Encourage medication adherence and educate on potential side effects.
• Support gradual re-engagement in social activities; defer job search until cognitive symptoms improve.
• Administer the next Invega Sustenna 117 mg IM in 4 weeks.
• Sent prescription refills to the pharmacy.
• Follow-up scheduled in 4 weeks

This was my plan of care in both cases; I took the lead in the 2nd one and was able to really connect. My preceptor prefers to focus on refilling medications and does not engage in therapy sessions or extensive discussions, while I prioritize conversation for improved understanding. We both diagnosed and treated in the same way.

Write a paper:

Briefly summarize:

The patient case, including all relevant information: the patient’s history, assessment findings, medications, any pertinent testing, presenting symptoms, and the final diagnosis (ensure patient confidentiality).
Compare Treatment Plans:

Describe your preceptor’s recommended treatment plan and interventions.
Explain the alternative treatment plan you would have recommended as a nurse practitioner based upon Clinical Practice Guidelines and Standards of Care.
Justify Your Approach:

Use evidence-based guidelines, clinical research, and relevant literature to support your alternative plan.
Discuss why you believe your approach would be effective, considering the patient’s history, condition, and individual needs.
Reflect on Differences:
Analyze the differences between your plan and your preceptor’s.
Consider factors such as clinical experience, knowledge, patient-centered care, and the influence of evidence-based practice in decision-making.
Lessons Learned:

Reflect on how this experience has influenced your clinical practice and approach to treatment planning.
Discuss how you can apply what you learned to future patient care.
How might you approach another provider professionally in the future when you find treatment plans differing during collaboration on the patient case?